Pule MA - Search Results

1

Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia.

Maciocia PM, Wawrzyniecka PA, Maciocia NC, Burley A, Karpanasamy T, Devereaux S, Hoekx M, O'Connor D, Leon T, Rapoz-D'Silva T, Pocock R, Rahman S, Gritti G, Yánez DC, Ross S, Crompton T, Williams O, Lee L, Pule MA, Mansour MR. Maciocia PM, et al. Among authors: pule ma. Blood. 2022 Jul 7;140(1):25-37. doi: 10.1182/blood.2021013648. Blood. 2022. PMID: 35507686 Free article.

2

Development of cellular immune responses against PAX5, a novel target for cancer immunotherapy.

Yan M, Himoudi N, Pule M, Sebire N, Poon E, Blair A, Williams O, Anderson J. Yan M, et al. Cancer Res. 2008 Oct 1;68(19):8058-65. doi: 10.1158/0008-5472.CAN-08-0153. Cancer Res. 2008. PMID: 18829564 Free article.

3

Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease.

Brewin J, Mancao C, Straathof K, Karlsson H, Samarasinghe S, Amrolia PJ, Pule M. Brewin J, et al. Blood. 2009 Nov 26;114(23):4792-803. doi: 10.1182/blood-2009-07-228387. Epub 2009 Sep 21. Blood. 2009. PMID: 19770360 Free article.

4

Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy.

Samarasinghe S, Mancao C, Pule M, Nawroly N, Karlsson H, Brewin J, Openshaw P, Gaspar HB, Veys P, Amrolia PJ. Samarasinghe S, et al. Blood. 2010 Jan 14;115(2):396-407. doi: 10.1182/blood-2009-08-235895. Epub 2009 Nov 4. Blood. 2010. PMID: 19890093 Free article.

5

Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.

Louis CU, Savoldo B, Dotti G, Pule M, Yvon E, Myers GD, Rossig C, Russell HV, Diouf O, Liu E, Liu H, Wu MF, Gee AP, Mei Z, Rooney CM, Heslop HE, Brenner MK. Louis CU, et al. Blood. 2011 Dec 1;118(23):6050-6. doi: 10.1182/blood-2011-05-354449. Epub 2011 Oct 7. Blood. 2011. PMID: 21984804 Free PMC article. Clinical Trial.

6

A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy.

Philip B, Kokalaki E, Mekkaoui L, Thomas S, Straathof K, Flutter B, Marin V, Marafioti T, Chakraverty R, Linch D, Quezada SA, Peggs KS, Pule M. Philip B, et al. Blood. 2014 Aug 21;124(8):1277-87. doi: 10.1182/blood-2014-01-545020. Epub 2014 Jun 26. Blood. 2014. PMID: 24970931 Free article.

7

Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells.

Ricciardelli I, Blundell MP, Brewin J, Thrasher A, Pule M, Amrolia PJ. Ricciardelli I, et al. Blood. 2014 Oct 16;124(16):2514-22. doi: 10.1182/blood-2014-01-553362. Epub 2014 Sep 2. Blood. 2014. PMID: 25185261 Free PMC article.

8

Chimeric antigen receptor T cells for ALL.

Amrolia PJ, Pule M. Amrolia PJ, et al. Lancet. 2015 Feb 7;385(9967):488-90. doi: 10.1016/S0140-6736(14)61729-3. Epub 2014 Oct 13. Lancet. 2015. PMID: 25319502 No abstract available.

9

CD19 chimeric antigen receptor T cell therapy for haematological malignancies.

Ghorashian S, Pule M, Amrolia P. Ghorashian S, et al. Br J Haematol. 2015 May;169(4):463-78. doi: 10.1111/bjh.13340. Epub 2015 Mar 5. Br J Haematol. 2015. PMID: 25753571 Free article. Review.

10

TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells.

Menger L, Gouble A, Marzolini MA, Pachnio A, Bergerhoff K, Henry JY, Smith J, Pule M, Moss P, Riddell SR, Quezada SA, Peggs KS. Menger L, et al. Among authors: pule m. Blood. 2015 Dec 24;126(26):2781-9. doi: 10.1182/blood-2015-08-664755. Epub 2015 Oct 27. Blood. 2015. PMID: 26508783 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page